BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 36.80
-0.10 (-0.27%)
At close: Jun 18, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.58 billion as of June 18, 2026. Its market cap has decreased by -12.80% in one year.
Market Cap
2.58B
Enterprise Value
1.53B
Revenue
154.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.80
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.58B, a decrease of -32.48%. That is a compound annual growth rate of -22.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.58B | -34.52% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 22.04B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.47B |
| Tripartite Therapeutics | 7.31B |
| Intelligene | 6.53B |
| Uwell Biopharma | 6.50B |
| Obigen Pharma | 3.84B |
| Pet Pharm Biotech | 2.91B |
| FullHope Biomedical | 1.16B |